Microbiology
-
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
This article has 29 authors:Reviewed by ScreenIT
-
Plasma irradiation efficiently inactivates the coronaviruses mouse hepatitis virus and SARS-CoV-2
This article has 6 authors:Reviewed by ScreenIT
-
SARS-CoV-2 infects carotid arteries: implications for vascular disease and organ injury in COVID-19
This article has 22 authors:Reviewed by ScreenIT
-
Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model
This article has 8 authors:Reviewed by ScreenIT
-
MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal Disease
This article has 7 authors:Reviewed by ScreenIT
-
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
This article has 42 authors:Reviewed by ScreenIT
-
The Anti-histamine Azelastine, Identified by Computational Drug Repurposing, Inhibits SARS-CoV-2 Infection in Reconstituted Human Nasal Tissue In Vitro
This article has 13 authors:Reviewed by ScreenIT
-
The discovery of gene mutations making SARS-CoV-2 well adapted for humans: host-genome similarity analysis of 2594 genomes from China, the USA and Europe
This article has 1 author:Reviewed by ScreenIT
-
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19
This article has 16 authors:Reviewed by ScreenIT
-
Spike mutation D614G alters SARS-CoV-2 fitness
This article has 22 authors:Reviewed by ScreenIT